Pilocarpine, Brimonidine, Oxymetazoline (PBO) Compound to Control Presbyopia Symptoms
Status:
Recruiting
Trial end date:
2021-09-15
Target enrollment:
Participant gender:
Summary
Safety and Efficacy of Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac
(PBOHB) ophthalmic compound to improve uncorrected near vision in healthy presbyopic patients
one hour after instillation.